Some patients with type 2 diabetes may benefit from intensive glycaemic and blood pressure control: A post-hoc machine learning analysis of ACCORD trial data.
Tianze JiaoHamed KianmehrYilu LinPiaopiao LiNaykky Singh OspinaHans K GhayeeMohammed RuziehVivian A FonsecaLizheng ShiPing ZhangStephen R BenoitPublished in: Diabetes, obesity & metabolism (2024)
Our findings suggest heterogeneous treatment effects of intensive glucose and BP control and could provide biomarkers for future clinical trials to identify more precise HbA1c and BP treatment goals for individualized medicine.